|
|
| | SGA 293 Basic information |
| Product Name: | SGA 293 | | Synonyms: | SGA 293;SGA360;1H-Indazole, 3-(2,4-dimethoxyphenyl)-1-(2-propen-1-yl)-7-(trifluoromethyl)-;1-allyl-3-(2,4-dimethoxyphenyl)-7-(trifluoromethyl)-1H-indazole;inhibit,Inhibitor,SGA360,SGA 360,SGA-360;1H-Indazole, 3-(2,4-dimethoxyphenyl)-1-(2-propenyl)-7-(trifluoromethyl)-;3-(2,4-dimethoxyphenyl)-1-(prop-2-en-1-yl)-7-(trifluoromethyl)-1H-indazole;SGA360, 10 mM in DMSO | | CAS: | 680611-86-3 | | MF: | C19H17F3N2O2 | | MW: | 362.35 | | EINECS: | | | Product Categories: | | | Mol File: | 680611-86-3.mol |  |
| | SGA 293 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO:10.0(Max Conc. mg/mL);27.6(Max Conc. mM)
DMF:20.0(Max Conc. mg/mL);55.2(Max Conc. mM)
Ethanol:2.0(Max Conc. mg/mL);5.52(Max Conc. mM) | | form | A crystalline solid | | color | White to off-white |
| | SGA 293 Usage And Synthesis |
| Uses | SGA360 was developed as a selective modulator of aryl hydrocarbon (Ah) receptor activity that exhibits anti-inflammatory properties. | | in vivo | SGA360 exhibits anti-inflammatory activity in vivo. |
| | SGA 293 Preparation Products And Raw materials |
|